Callum Borchers

2 weeks ago | wsj.com | Callum Borchers

Gen Zers recently overtook baby boomers in the workforce, posing new challenges for business leadersTua Tagovailoa, the 27-year-old quarterback of the Miami Dolphins, wants to throw out his generation’s reputation for being soft. Good thing he has a strong arm. He says it’s a misconception that Gen Zers, people born from 1997 to 2012 who were raised with safe spaces and trigger warnings, can’t handle harsh realities.

2 weeks ago | wsj.com | Callum Borchers

“Leadership traditionally looked like someone who had the demeanor of authority and demanded respect, and I just don’t think in this generation that works,” he says. “When I get called out for something, I want to know it’s coming from a good place.”Business leaders sometimes look to sports for tips on winning attitudes and championship work ethics. The real playbook worth borrowing now, more than ever, is about managing Gen Zers.

3 weeks ago | wsj.com | Callum Borchers

American society may look increasingly vitriolic through the lens of social media, where Fisher, 36, has attracted millions of followers with his video tips for handling tense situations. At work, however, people often use technology to duck conflict. Why face a tough conversation when you can ignore that uncomfortable Slack message or enlist ChatGPT to compose another vanilla email? In the future, offices could become even more passive-aggressive, unless we practice the art of disagreement.

3 weeks ago | wsj.com | Callum Borchers

Insurance for weight-loss drugs like Ozempic is shaping up as the next power struggle between employers and employees. Some companies have curbed or ended coverage for blockbuster weight-loss treatments known as GLP-1s. This has been to the chagrin of employees who can’t afford to pay for the drugs on their own. Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

3 weeks ago | livemint.com | Callum Borchers

Summary Questions about insurance coverage for weight-loss drugs are getting more intense as cheaper alternatives go off the market. This is a Mint Premium article gifted to you. Subscribe to enjoy similar stories. Insurance for weight-loss drugs like Ozempic is shaping up as the next power struggle between employers and employees. Some companies have curbed or ended coverage for blockbuster weight-loss treatments known as GLP-1s.